The Trial Innovation Network is a new collaborative initiative within the CTSA Program and is composed of three key organizational partners – the CTSA Program Hubs, the Trial Innovation Centers (TICs), and the Recruitment Innovation Center (RIC).
The vision for the Trial Innovation Network is to innovatively address critical roadblocks in clinical trials and accelerate the translation of novel interventions into life-saving therapies. The Trial Innovation Network is a collaborative national network that focuses on operational innovation, operational excellence and collaboration and will leverage the expertise and resources of the CTSA Program. The Trial Innovation Network will feature a single IRB system, master contracting agreements, quality by design approaches, and a focus on evidence-based strategies to recruitment and patient engagement.
The goal of the Trial Innovation Network is to not only execute trials better, faster, and more cost-efficiently but, importantly, to be a national laboratory to study, understand and innovate the process of conducting clinical trials.
The investigators are currently building the key elements of the Trial Innovation Network. The goal is to start early projects as soon as possible and collaborate with other NIH Institutes and partners to launch clinical trials in 2017.
For a description of the organization and key elements of the Trial Innovation Network, please see the Key Terminology and Definitions.
In this webinar, we will discuss our CCTS’s approach to recruitment consultation for clinical translational studies, and describe the tools and approaches we employ to track and improve accrual efforts.
In this webinar, we will discuss the challenges in engaging underrepresented populations in clinical studies and how understating the social/cultural/environmental context (social determinants of health) of these individuals could benefit our efforts in clinical study accrual.
We've received your information.